Prevalence of anxiety disorders and its co-occurrence with substance use disorder: a clinical study
Abstract Background Epidemiological studies are necessary to develop diagnostic standards for mental disorders. Therefore, this study investigated the prevalence of anxiety disorders, and its correlation with different substances used by patients diagnosed with substance use disorder referred to the...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SpringerOpen
2022-04-01
|
| Series: | Middle East Current Psychiatry |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s43045-022-00197-x |
| _version_ | 1818278983392821248 |
|---|---|
| author | Shiva Soraya Mehri Mahdavi Mahdieh Saeidi Ruohollah Seddigh Sara Nooraeen Mehrdad Sadri Amir Jahanian Najafabadi |
| author_facet | Shiva Soraya Mehri Mahdavi Mahdieh Saeidi Ruohollah Seddigh Sara Nooraeen Mehrdad Sadri Amir Jahanian Najafabadi |
| author_sort | Shiva Soraya |
| collection | DOAJ |
| description | Abstract Background Epidemiological studies are necessary to develop diagnostic standards for mental disorders. Therefore, this study investigated the prevalence of anxiety disorders, and its correlation with different substances used by patients diagnosed with substance use disorder referred to the Iran Psychiatric Hospital located in Tehran, Iran. Two hundred ninety-two male patients aged 18–65 (Meanage = 36.11, SD = 10.55) were recruited according to the available participant pool. Structured Clinical Interview for DSM-V Axis I Disorders was used to investigate their simultaneous anxiety disorders, and then the correlations with the different substances used during the past year before our study were considered. Based on clinical evaluation and structured psychiatric interviews, we investigated panic disorder, agoraphobia, social anxiety disorder, and generalized anxiety disorder. Results Results revealed that generalized anxiety disorder was the most common type of anxiety disorder among subjects of the current study. Further investigations revealed that panic disorder was significantly correlated with the abuse of cannabis (r = 0.116, p value = 0.047), tramadol (r = 0.205, p value < 0.001), and LSD (r = 0.197, p value = 0.001). Moreover, social anxiety disorder was correlated with cannabis (r = 0.124, p value = 0.035), opium (r = 0.186, p value = 0.001), methadone (r = 0.152, p value = 0.010), tramadol (r = 0.258, p value < 0.001), alcohol (r = 0.133, p value = 0.023), LSD (r = 0.123, p value = 0.036), and benzodiazepines (r = 0.168, p value = 0.004). The results indicated that none of the substances was correlated with generalized anxiety disorder as well as agoraphobia. However, agoraphobia had correlations with the intravenous injection as the main route of administration (r = 0.174, p value = 0.004). Conclusions Here this study supports the notion that co-occurrence of psychiatric disorders is relatively common and must be taken into consideration when assessing a patient and following up the treatment. |
| first_indexed | 2024-12-12T23:26:06Z |
| format | Article |
| id | doaj.art-c264d62ccc3c4ac7a8ae8e1007ba2991 |
| institution | Directory Open Access Journal |
| issn | 2090-5416 |
| language | English |
| last_indexed | 2024-12-12T23:26:06Z |
| publishDate | 2022-04-01 |
| publisher | SpringerOpen |
| record_format | Article |
| series | Middle East Current Psychiatry |
| spelling | doaj.art-c264d62ccc3c4ac7a8ae8e1007ba29912022-12-22T00:08:03ZengSpringerOpenMiddle East Current Psychiatry2090-54162022-04-012911810.1186/s43045-022-00197-xPrevalence of anxiety disorders and its co-occurrence with substance use disorder: a clinical studyShiva Soraya0Mehri Mahdavi1Mahdieh Saeidi2Ruohollah Seddigh3Sara Nooraeen4Mehrdad Sadri5Amir Jahanian Najafabadi6Research Center for Addiction and Risky Behaviors, Iran University of Medical SciencesResearch Center for Addiction and Risky Behaviors, Iran University of Medical SciencesResearch Center for Addiction and Risky Behaviors, Iran University of Medical SciencesSpiritual Health Research Center, Iran University of Medical SciencesMental Health Research Center, School of Behavioral Sciences and Mental Health, Iran University of Medical SciencesFaculty of Medicine, Tehran University of Medical SciencesDepartment of Psychology & Methods, Jacobs University BremenAbstract Background Epidemiological studies are necessary to develop diagnostic standards for mental disorders. Therefore, this study investigated the prevalence of anxiety disorders, and its correlation with different substances used by patients diagnosed with substance use disorder referred to the Iran Psychiatric Hospital located in Tehran, Iran. Two hundred ninety-two male patients aged 18–65 (Meanage = 36.11, SD = 10.55) were recruited according to the available participant pool. Structured Clinical Interview for DSM-V Axis I Disorders was used to investigate their simultaneous anxiety disorders, and then the correlations with the different substances used during the past year before our study were considered. Based on clinical evaluation and structured psychiatric interviews, we investigated panic disorder, agoraphobia, social anxiety disorder, and generalized anxiety disorder. Results Results revealed that generalized anxiety disorder was the most common type of anxiety disorder among subjects of the current study. Further investigations revealed that panic disorder was significantly correlated with the abuse of cannabis (r = 0.116, p value = 0.047), tramadol (r = 0.205, p value < 0.001), and LSD (r = 0.197, p value = 0.001). Moreover, social anxiety disorder was correlated with cannabis (r = 0.124, p value = 0.035), opium (r = 0.186, p value = 0.001), methadone (r = 0.152, p value = 0.010), tramadol (r = 0.258, p value < 0.001), alcohol (r = 0.133, p value = 0.023), LSD (r = 0.123, p value = 0.036), and benzodiazepines (r = 0.168, p value = 0.004). The results indicated that none of the substances was correlated with generalized anxiety disorder as well as agoraphobia. However, agoraphobia had correlations with the intravenous injection as the main route of administration (r = 0.174, p value = 0.004). Conclusions Here this study supports the notion that co-occurrence of psychiatric disorders is relatively common and must be taken into consideration when assessing a patient and following up the treatment.https://doi.org/10.1186/s43045-022-00197-xAnxiety disordersSubstance use disorderClinical patientsPsychiatric disorders |
| spellingShingle | Shiva Soraya Mehri Mahdavi Mahdieh Saeidi Ruohollah Seddigh Sara Nooraeen Mehrdad Sadri Amir Jahanian Najafabadi Prevalence of anxiety disorders and its co-occurrence with substance use disorder: a clinical study Middle East Current Psychiatry Anxiety disorders Substance use disorder Clinical patients Psychiatric disorders |
| title | Prevalence of anxiety disorders and its co-occurrence with substance use disorder: a clinical study |
| title_full | Prevalence of anxiety disorders and its co-occurrence with substance use disorder: a clinical study |
| title_fullStr | Prevalence of anxiety disorders and its co-occurrence with substance use disorder: a clinical study |
| title_full_unstemmed | Prevalence of anxiety disorders and its co-occurrence with substance use disorder: a clinical study |
| title_short | Prevalence of anxiety disorders and its co-occurrence with substance use disorder: a clinical study |
| title_sort | prevalence of anxiety disorders and its co occurrence with substance use disorder a clinical study |
| topic | Anxiety disorders Substance use disorder Clinical patients Psychiatric disorders |
| url | https://doi.org/10.1186/s43045-022-00197-x |
| work_keys_str_mv | AT shivasoraya prevalenceofanxietydisordersanditscooccurrencewithsubstanceusedisorderaclinicalstudy AT mehrimahdavi prevalenceofanxietydisordersanditscooccurrencewithsubstanceusedisorderaclinicalstudy AT mahdiehsaeidi prevalenceofanxietydisordersanditscooccurrencewithsubstanceusedisorderaclinicalstudy AT ruohollahseddigh prevalenceofanxietydisordersanditscooccurrencewithsubstanceusedisorderaclinicalstudy AT saranooraeen prevalenceofanxietydisordersanditscooccurrencewithsubstanceusedisorderaclinicalstudy AT mehrdadsadri prevalenceofanxietydisordersanditscooccurrencewithsubstanceusedisorderaclinicalstudy AT amirjahaniannajafabadi prevalenceofanxietydisordersanditscooccurrencewithsubstanceusedisorderaclinicalstudy |